Search Results 171-180 of 15897 for pharmacogenetics
Learn about how our experts use testing, genetic counseling and treatments to help people with a family history of heart disease at risk of heart attacks.
About this study. The purpose of this study is to identify patients with rare genetic disorders that may potentially benefit from an ASO therapeutic based ...
About this study. Laboratory studies suggest that the study drug may stop cancer cells from growing by affecting an interaction between proteins in the ...
The purpose of this study is to develop an AI-driven biomarker based on FDG-PET images to track longitudinal brain changes in asymptomatic (n = 15) and ...
Pegfilgrastim-jmdb injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...
About this study. The purpose of this study is to attempt to identify potential disruptions of genes at chromosome rearrangement breakpoints only detectable ...
The purpose of this study is to assess genetic predictors of chemotherapy-related amenorrhea in breast cancer survivors of both European and non-European ...
Peginterferon alfa-2b injection is used alone or together with ribavirin and another drug called a hepatitic C virus (HCV) NS3/4A protease inhibitor (eg, ...
When prescribing a medication for you, your physician considers many factors, including your age, sex, weight and current health conditions.
The purpose of this study is to identify susceptibility genes for venous thromboembolism (VTE) using conventional and novel genetic-epidemiologic methods in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.